2023
1.) Li L, Bowling S, McGeary SE, Yu Q, Lemke B, Alcedo K, Jia Y, Liu X, Ferreira M, Klein AM, Wang SW, Camargo FD. A mouse model with high clonal barcode diversity for joint lineage, transcriptomic, and epigenomic profiling in single cells. Cell. 2023 Nov 9;186(23):5183-5199.e22. doi: 10.1016/j.cell.2023.09.019. Epub 2023 Oct 17. PubMed PMID: 37852258.
2.) Kim KM, Mura-Meszaros A, Tollot M, Krishnan MS, Gründl M, Neubert L, Groth M, Rodriguez-Fraticelli A, Svendsen AF, Campaner S, Andreas N, Kamradt T, Hoffmann S, Camargo FD, Heidel FH, Bystrykh LV, de Haan G, von Eyss B. Taz protects hematopoietic stem cells from an aging-dependent decrease in PU.1 activity. Nat Commun. 2022 09 03; 13(1):5187. PMID: 36057685; PMCID: PMC9440927.
3.) He S, Lei P, Kang W, Cheung P, Xu T, Mana M, Park CY, Wang H, Imada S, Russell JO, Wang J, Wang R, Zhou Z, Chetal K, Stas E, Mohad V, Bruun-Rasmussen P, Sadreyev RI, Hodin RA, Zhang Y, Breault DT, Camargo FD, Yilmaz ÖH, Fredberg JJ, Saeidi N. Stiffness Restricts the Stemness of the Intestinal Stem Cells and Skews Their Differentiation Toward Goblet Cells. Gastroenterology. 2023 Jun;164(7):1137-1151.e15. doi: 10.1053/j.gastro.2023.02.030. Epub 2023 Mar 4. PubMed PMID: 36871599; PubMed Central PMCID: PMC10200762.
2022
1.) Patel S, Christodoulou C, Weinreb C, Yu Q, Lummertz da Rocha E, Pepe-Mooney BP, Bowling S, Li L, Garcia-Osorio F, Daley GQ, Camargo FD. Embryonic multipotent progenitors specified during the definitive wave of hematopoiesis represent a significant source of adult blood. 2022, Nature in press
2.) Russell JO, Camargo FD. Hippo signalling in the liver: role in development, regeneration and disease. Nat Rev Gastroenterol Hepatol. 2022 05; 19(5):297-312. PMID: 35064256; PMCID: PMC9199961.
2021
1.) Van Egeren D, Escabi J, Nguyen M, Liu S, Reilly CR, Patel S, Kamaz B, Kalyva M, DeAngelo DJ, Galinsky I, Wadleigh M, Winer ES, Luskin MR, Stone RM, Garcia JS, Hobbs GS, Camargo FD, Michor F, Mullally A, Cortes-Ciriano I, Hormoz S. Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms. Cell Stem Cell. 2021 Mar 4;28(3):514-523.e9.
2.) Shalhout SZ, Yang PY, Grzelak EM, Nutsch K, Shao S, Zambaldo C, Iaconelli J, Ibrahim L, Stanton C, Chadwick SR, Wu X, Chatterjee AK, Shen W, Camargo FD*, Schultz PG*, Bollong MJ*. YAP-dependent proliferation by a small molecule targeting annexin A2. Nature Chemical Biology. 2021 Jul;17(7):767-775. doi: 10.1038/s41589-021-00755-0. *Co-corresponding
3.) Sommerkamp P, Romero-Mulero MC, Narr A, Ladel L, Hustin L, Rodriguez-Fraticelli A, Camargo FD, Perié L, Trumpp A, Cabezas-Wallscheid N. Mouse multipotent progenitor 5 cells are located at the interphase between hematopoietic stem and progenitor cells. Blood 2021 Jun 10;137(23):3218-3224. doi: 10.1182/blood.2020007876.
4.) Gao R, Kalathur RKR, Coto-Llerena M, Ercan C, Buechel D, Shuang S, Piscuoglio S, Dill MT, Camargo FD, Christofori G, Tang F. YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis. EMBO Mol Med 2021 Dec 7;13(12):e14351. doi: 10.15252/emmm.202114351
2020
1.) Christodoulou C, Spencer JA, Yeh SA, Turcotte R, Kokkaliaris KD, Panero R, Ramos A, Guo G, Seyedhassantehrani N, Esipova TV, Vinogradov SA, Rudzinskas S, Zhang Y, Perkins AS, Orkin SH, Calogero RA, Schroeder T, Lin CP*, Camargo FD*. Live-animal imaging of native haematopoietic stem and progenitor cells. Nature. 2020 Feb 1; 578(7794): 278-283. PubMed PMID: 32025033; PubMed Central PMCID: PMC7021587. *Co-corresponding authors
2.) Weinreb C, Rodriguez-Fraticelli A, Camargo FD*, Klein AM*. Lineage tracing on transcriptional landscapes links state to fate during differentiation. Science (New York, N.Y.). 2020 Feb 14; 367(6479). PubMed PMID: 31974159. *Co-senior authors
3.)Mooring M, Fowl BH, Lum SZC, Liu Y, Yao K, Softic S, Kirchner R, Bernstein A, Singhi AD, Jay DG, Kahn CR, Camargo FD, Yimlamai D. Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis. Hepatology (Baltimore, Md.). 2020 May 1; 71(5): 1813-1830. PubMed PMID: 31505040; PubMed Central PMCID: PMC7062580.
4.) Li Q, Sun Y, Jarugumilli GK, Liu S, Dang K, Cotton JL, Xiol J, Chan PY, DeRan M, Ma L, Li R, Zhu LJ, Li JH, Leiter AB, Ip YT, Camargo FD, Luo X, Johnson RL, Wu X, Mao J. Lats1/2 Sustain Intestinal Stem Cells and Wnt Activation through TEAD-Dependent and Independent Transcription. Cell stem cell. 2020 May 7; 26(5): 675-692.e8. PubMed PMID: 32259481.
5.) Bowling S, Sritharan D, Osorio FG, Nguyen M, Cheung P, Rodriguez-Fraticelli A, Patel S, Yuan WC, Fujiwara Y, Li BE, Orkin SH, Hormoz S*, Camargo FD*. An Engineered CRISPR-Cas9 Mouse Line for Simultaneous Readout of Lineage Histories and Gene Expression Profiles in Single Cells. Cell. 2020 May 14. PubMed PMID: 32413320. *Co-corresponding
6.) Rodriguez-Fraticelli AE, Weinreb C, Wang SW, Migueles RP, Jankovic M, Usart M, Klein AM, Lowell S, Camargo FD. Single-cell lineage tracing unveils a role for TCF15 in haematopoiesis. Nature. 2020 Jul;583(7817):585-589. doi: 1038/s41586-020-2503-6. Epub 2020 Jul 15. PMID: 32669716; PMCID: PMC7579674.
7.) Cheung P, Xiol J, Dill MT, Yuan WC, Panero R, Roper J, Osorio FG, Maglic D, Li Q, Gurung B, Calogero RA, Yilmaz ÖH, Mao J, Camargo FD. Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer. Cell Stem Cell. 2020 Oct 1;27(4):590-604.e9. doi: 10.1016/j.stem.2020.07.003. Epub 2020 Jul 29. PMID: 32730753.
8.) Hurley K, Ding J, Villacorta-Martin C, Herriges MJ, Jacob A, Vedaie M, Alysandratos KD, Sun YL, Lin C, Werder RB, Huang J, Wilson AA, Mithal A, Mostoslavsky G, Oglesby I, Caballero IS, Guttentag SH, Ahangari F, Kaminski N, Rodriguez-Fraticelli A, Camargo FD, Bar-Joseph Z, Kotton DN. Reconstructed Single-Cell Fate Trajectories Define Lineage Plasticity Windows during Differentiation of Human PSC-Derived Distal Lung Progenitors. Cell Stem Cell. 2020 Apr 2;26(4):593-608.e8. doi: 10.1016/j.stem.2019.12.009. Epub 2020 Jan 30. PMID: 32004478
2019
1.) Pepe-Mooney BJ, Dill MT, Alemany A, Ordovas-Montanes J, Matsushita Y, Rao A, Sen A, Miyazaki M, Anakk S, Dawson PA, Ono N, Shalek AK, van Oudenaarden A, Camargo FD. Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and Regeneration. Cell Stem Cell. 2019 May 1. pii: S1934-5909(19)30153-5. doi: 10.1016/j.stem.2019.04.004. PMID: 31080134.2. Yuan WC, Pepe-Mooney B, Galli GG, Dill MT, Huang HT, Hao M, Wang Y, Liang H, Calogero RA, Camargo FD. NUAK2 is a critical YAP target in liver cancer. Nat Commun. 2018 Nov 16;9(1):4834. doi: 10.1038/s41467-018-07394-5. PubMed PMID: 30446657; PubMed Central PMCID: PMC6240092.
2018
1.) Osorio FG, Rosendahl Huber A, Oka R, Verheul M, Patel SH, Hasaart K, de la Fonteijne L, Varela I, Camargo FD, van Boxtel R. Somatic Mutations Reveal Lineage Relationships and Age-Related Mutagenesis in Human Hematopoiesis. Cell Rep. 2018 Nov 27;25(9):2308-2316.e4. doi: 10.1016/j.celrep.2018.11.014. PMID: 30485801
2.) Yuan W, Pepe-Mooney B, Galli GG, Dill MT, Huang H, Hao M, Wang Y, Liang H, Calogero RA, Camargo FD. NUAK2 is a critical YAP target in liver cancer. Nat Commun. 2018 Nov 16;9(1):4834. doi: 10.1038/s41467-018-07394-5. PMID: 30446657
3.) Maglic D, Schlegelmilch K, Dost AF, Panero R, Dill MT, Calogero RA, Camargo FD. YAP-TEAD signaling promotes basal cell carcinoma development via a c-JUN/AP1 axis. EMBO J. 2018 Sep 3;37(17). pii: e98642. doi: 10.15252/embj.201798642. Epub 2018 Jul 23. PMID: 30037824
4.) Rodriguez-Fraticelli AE, Wolock SL, Weinreb CS, Panero R, Patel SH, Jankovic M, Sun J, Calogero RA, Klein AM, Camargo FD. Clonal analysis of lineage fate in native haematopoiesis. Nature. 2018 Jan 11;553(7687):212-216. doi: 10.1038/nature25168. Epub 2018 Jan 3. PubMed PMID: 29323290; PubMed Central PMCID: PMC5884107.
5.) Cox AG, Tsomides A, Yimlamai D, Hwang KL, Miesfeld J, Galli GG, Fowl BH, Fort M, Ma KY, Sullivan MR, Hosios AM, Snay E, Yuan M, Brown KK, Lien EC, Chhangawala S, Steinhauser ML, Asara JM, Houvras Y, Link B, Vander Heiden MG, Camargo FD, Goessling W. Yap regulates glucose utilization and sustains nucleotide synthesisto enable organ growth. EMBO J. 2018 Nov 15;37(22). pii: e100294. doi:10.15252/embj.2018100294. Epub 2018 Oct 22. PubMed PMID: 30348863; PubMed Central PMCID: PMC6236334.
6.) Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, Jeong KJ, Tsang YH, Moreno D, Bhavana VH, Peng X, Ge Z, Chen H, Li J, Chen Z, Zhang H, Han L, Du D, Creighton CJ, Mills GB; Cancer Genome Atlas Research Network, Camargo F, Liang H. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer. Cell Rep. 2018 Oct 30;25(5):1304-1317.e5. doi:10.1016/j.celrep.2018.10.001. PubMed PMID: 30380420; PubMed Central PMCID:PMC6326181.
2017
1.) Hu Y, Shin DJ, Pan H, Lin Z, Dreyfuss JM, Camargo FD, Miao J, Biddinger SB. YAP suppresses gluconeogenic gene expression through PGC1α. Hepatology. 2017 Dec;66(6):2029-2041. doi: 10.1002/hep.29373. Epub 2017 Oct 30. PubMed PMID: 28714135.
2.) Patel SH, Camargo FD, Yimlamai D. Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis. Gastroenterology. 2017 Feb;152(3):533-545. doi: 10.1053/j.gastro.2016.10.047. Epub 2016 Dec 19. Review. PubMed PMID: 28003097; PubMed Central PMCID: PMC5285449.
3.) Katsuda T, Kawamata M, Hagiwara K, Takahashi RU, Yamamoto Y, Camargo FD, Ochiya T. Conversion of Terminally Committed Hepatocytes to Culturable Bipotent Progenitor Cells with Regenerative Capacity. Cell Stem Cell. 2017 Jan 5;20(1):41-55. doi: 10.1016/j.stem.2016.10.007. Epub 2016 Nov 10. PubMed PMID: 27840021.
2016
1.) Cox AG, Hwang KL, Brown KK, Evason KJ, Beltz S, Tsomides A, O'Connor K, Galli GG, Yimlamai D, Chhangawala S, Yuan M, Lien EC, Wucherpfennig J, Nissim S, Minami A, Cohen DE, Camargo FD, Asara JM, Houvras Y, Stainier DY, Goessling W. Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth. Nat Cell Biol 2016; 18:886-96. PubMed
2015
1.)Yimlamai D, Fowler BH, Camargo FD (2015). Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer. J Hepatol, Dec;63(6):1491-501.
2.) Galli G, Carrara M, Yuan WC, Valdes-Quezada C, Gurung B, Pepe-Mooney B, Zhang T, Geeven G, Gray NS, de Laat W, Calogero RA, and Camargo FD (2015). YAP drives growth by controlling transcriptional pause release from dynamic enhancers. Mol Cell, Oct 15;60(2):328-337.
3.) Gentner B, Pochert N, Rouhi A, Boccalatte F, Plati T, Berg T, Sun SM, Mah SM, Mirkovic-Hösle M, Ruschmann J, Muranyi A, Leierseder S, Argiropoulos B, Starczynowski DT, Karsan A, HeuserM, Hogge D, Camargo FD, Engelhardt S, Döhner H, Buske C, Jongen-Lavrencic M, Naldini L,Humphries RK, Kuchenbauer F. (2015) MicroRNA-223 dose-levels fine-tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia. Exp Hematol. 2015 Jul 8. pii: S0301-472X(15)00511-1
2014
1.) Sun J, Ramos A, Chapman B, Johnnidis JB, Le L, Ho YJ, Klein A, Hofmann O, and Camargo FD (2014) Clonal dynamics of native hematopoiesis. Nature, Oct 16;514(7522):322-7. PMID: 25296256, PMCID: PMC4408613.
2.) Ganem NJ, Cornils H, Chiu SY, O'Rourke KP, Arnaud J, Yimlamai D, Thery M, Camargo FD, Pellman D (2014). Cytokinesis failure triggers hippo tumor suppressor pathway activation. Cell.158(4):833-48. PMCID: PMC4136486.
3.) Tremblay A, Misoaglia E, Galli GG, Hetmer S, Urcia R, Carrara M, Judson RM, Thway K, Nadal G, Selfe J, Murray G, Calogero R, De Bari C, Zammit PS, Delorenzi M, Wagers AJ, Shipley J, Wackerhage H, and Camargo FD (2014). The Hippo Transducer Yap1 Transforms Activated Satellite Cells and is a Potent Effector of Embryonal Rhabdomyosarcoma Formation. Cancer Cell, Aug 11;26(2):273-87
4.) Yimlamai D, Christodoulou C, Galli G, Yanger K, Pepe-Mooney B, Gurung B, Shrestha K, Cahan P, Stanger BZ and Camargo FD (2014). Hippo signaling regulates liver cell fate. Cell, 157(6):1324-38. PMCID: PMC4136468
5.) Grijalva JL, Huizenga M, Mueller K, Rodriguez S, Brazzo J, Camargo F, Sadri-Vakili G, Vakili K. (2014). Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol. 307(2):G196-204.
6.) Zhang H, von Gise A, Liu Q, Hu T, Tian X, He L, Pu W, Huang X, He L, Cai CL, Camargo FD, Pu WT, Zhou B (2014). Yap1 is required for endothelial to mesenchymal transition of the atrioventricular cushion. J Biol Chem.289(27):18681-92. PMCID: PMC4081914.
7.) Mori M, Triboulet R, Mohseni M, Schlegelmilch K, Camargo FD* and Gregory R* (2014). Hippo signaling regulates Microprocessor and links cell-density dependent miRNA biogenesis to cancer. Cell. 156(5):893-906. PMCID: PMC398229 *Co-corresponding authors
8.)Lau AN, Curtis SJ, Fillmore CM, Rowbotham SP, Mohseni M, Wagner DE, Beede AM, Montoro DT, Sinkevicius KW, Walton ZE, Barrios J, Weiss DJ, Camargo FD, Wong KK, Kim CF (2014). Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis. EMBO J. 33(5):468-81. PMCID: PMC3989628
9.) Mohseni M, Sun J, Lau A, Curtis S, Goldsmith J, Fox VL, Wei C, Frazier M, Samson O, Wong KK, Kim C, and Camargo FD (2014). A genetic screen identifies an LKB1/MARK signaling axis controlling the Hippo/YAP pathway. Nature Cell Biology. 16(1):108-17. PMCID: PMC4159053
2013
1.) Halder G, Camargo FD. (2013). The hippo tumor suppressor network: from organ size control to stem cells and cancer. Cancer Res.73(21):6389-92. PMCID: PMC4030874.
2.) Zhang Y, Owens K, Hatem L, Glass CH, Karuppaiah K, Camargo F, Perkins AS. (2013) Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia. Blood. 122(16): 2888-92. PMCID: PMC3799001
3.) Wu H, Xiao Y, Zhang S, Ji S, Wei L, Fan F, Geng J, Tian J, Sun X, Qin F, Jin C, Lin J, Yin ZY, Zhang T, Luo L, Li Y, Song S, Lin SC, Deng X, Camargo F, Avruch J, Chen L, Zhou D. (2013) The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense. Cell Rep. 3(5): 1663-77. PMCID: PMC3855275.
4.) Barry ER, Camargo FD. (2013) The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development. Curr Opin Cell Biol. 25(2): 247-53.
5.) Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, Yan KS, Fuchs CS, Magness ST, Smits R, Ogino S, Kuo CJ, Camargo FD. (2013) Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature. 493(7430): 106-10. PMCID: PMC3536889
2012
1.) Tumaneng K, Schlegelmilch K, Russell RC, Yimlamai D, Basnet H, Mahadevan N, Fitamant J, Bardeesy N, Camargo FD, Guan KL. (2012) YAP mediates crosstalk between the Hippo and PI (3) K– TOR pathways by suppressing PTEN via miR-29. Nat Cell Biol. 14(12): 1322-9. PMCID: PMC4019071
2.) Judson RN*, Tremblay AM*, Knopp P, White RB, Urcia R, De Bari C, Zammit PS**, Camargo FD**, Wackerhage H**. (2012) The Hippo pathway member Yap plays a key role in influencing the fate decision in muscle satellite cells. Journal of Cell Science; 125(24): 6009-19. PMCID: PMC3585517 *co-first authors, **joint senior authors
3.) Tremblay AM, Camargo FD. (2012) Hippo signaling in mammalian stem cells. Seminars in Cell and Developmental Biology. 23(7): 818-26.
4.) Ramos A and Camargo FD, (2012) Hippo signaling and stem cells. Trends in Cell Biology. 22(7):339-46. PMCID: PMC3383919
5.) von Gise A, Lin Z, Schlegelmilch K, Honor LB, Pan GM, Buck JN, Ma Q, Ishiwata T, Zhou B, Camargo FD, Pu WT. (2012) YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc Natl Acad Sci USA. 109(7):2394-9. PMCID: PMC3289361
2011
1.) Zhou D, Zhang Y, Wu H, Barry E, Yin Y, Lawrence E, Dawson D, Willis JE, Markowitz SD, Camargo FD, Avruch J. (2011) Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci U S A. 108(49): E1312-20. PMCID: PMC3241824
2.) Kuchenbauer F, Mah SM, Heuser M, McPherson A, Ruschmann J, Rouhi A, et al. (2011). Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells. Blood. 118(12):3350-8.
3.) Zhang Y, Stehling-Sun S, Lezon-Geyda K, Juneja SC, Coillard L, Chatterjee G, Wuertzer CA, Camargo F*, Perkins AS*. (2011) PR-domain-containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function. Blood.118 (14): 3853-61. *Co-corresponding authors
4.) Silvis MR, Kreger BT, Lien WH, Klezovitch O, Rudakova GM, Camargo FD, Lantz DM, Seykora JT, Vasioukhin V. (2011) α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci Signal; 4(174). PMCID: PMC3366274
5.) Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D, Kreger BT, Vasioukhin V, Avruch J, Brummelkamp TR, Camargo FD. (2011) Yap1 Acts Downstream of α-Catenin to Control Epidermal Proliferation. Cell. 144(5): 782-95. PMCID: PMC3237196
2010
1.) Carette JE, Pruszak J, Varadarajan M, Blomen VA, Gokhale S, Camargo FD, Wernig M, Jaenisch R, Brummelkamp TR. (2010) Generation of iPSCs from cultured human malignant cells. Blood 115(20):4039-42. PMCID: PMC2875096
2009
1.) Stehling-Sun S, Dade J, Nutt SL, DeKoter RP, Camargo FD. (2009) Regulation of lymphoid versus myeloid fate ‘choice’ by the transcription factor Mef2c. Nature Immunology 10(3):289-96
2008
1.) Baek D, Shin C, Villen J, Camargo FD, Gygi S, Bartel DP. (2008) The impact of microRNAs on target protein output. Nature 455(7209):64-71. PMCID: PMC2745094
2.) Johnnidis JB, Harris MH, Wheeler TR, Stehling-Sun S, Lam MH, Brummelkamp TR, Fleming MD, Camargo FD. (2008) Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451(7182):1125-29
2007
1.) Camargo FD*, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, Brummelkamp TR*. (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol. 17(23):2054-60 *Equal senior author contribution
2.) Lengner C, Camargo FD, Hoechedlinger K, Welstead GG, Zaidi S, Gokhale S, Scholer HR, Tomilinin A, Jaenisch R. (2007) Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell. 1(4):403-415. PMCID: PMC2151746
2006
1.) Camargo FD, Chambers SM, Drew E, McNagny KM, Goodell MA. (2006) Hematopoietic stem cells do not engraft with absolute efficiencies. Blood 107(2):501-7. PMCID: PMC1895609
2004
1.) Camargo FD, Finegold M, Goodell MA. (2004) Hematopoietic myelomonocytic cells are the major source of hepatic fusogenic partners. J Clin Invest. 113(9):1266-1270. PMCID: PMC398434
2.) Camargo FD, Chambers SM, Goodell MA. Stem cell plasticity: from transdifferentiation to macrophage fusion. Cell Prolif. 2004;37(1):55-65.
2003
1.) Camargo FD, Green R, Capetenaki Y, Jackson KA, Goodell MA. (2003) Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nature Medicine. 9(12):1520--7.
2.) Olmsted-Davis EA, Gugala Z, Camargo FD, Gannon F, Jackson K, Anderson-Kienstra K, Shine HD, Lindsey RW, Hirschi KK, Goodell MA, Brenner M, Davis AR. (2003) Primitive adult hematopoietic stem cells can function as osteoblast precursors. PNAS. 100(26):15877-82. PMCID: PMC307661.
2002
1.) McKinney-Freeman SL, Jackson KA, Camargo FD, Ferrari G, Mavilio F, Goodell MA. (2002) Muscle-derived hematopoietic stem cells are hematopoietic in origin. PNAS. 5(99):1341-6. PMCID: PMC122192.
2001
1.) Camargo FD, Erickson RP, Garver WS, Hossain GS, Carbone PN, Heidenreich RA, Blanchard J. (2001) Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease. Life Sci. 70(2):131-42.
2000
1.) Camargo FD, Huey-Louie DA, Finn AV, Sassani AB, Cozen AE, Moriwaki H, Schneider DB, Agah R, Dichek DA. (2000) Germline incorporation of a replication-defective adenoviral vector in mice does not alter immune responses to adenoviral vectors. Mol Ther. 2(5):496-504.